IMS Capital Management Has $1.42 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

IMS Capital Management increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 1.2% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,759 shares of the healthcare conglomerate’s stock after acquiring an additional 32 shares during the period. UnitedHealth Group comprises about 0.9% of IMS Capital Management’s portfolio, making the stock its 28th largest position. IMS Capital Management’s holdings in UnitedHealth Group were worth $1,417,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in UNH. Norges Bank acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $4,478,185,000. Arrowstreet Capital Limited Partnership grew its position in UnitedHealth Group by 1,682.4% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock valued at $1,372,606,000 after purchasing an additional 2,540,538 shares in the last quarter. The Manufacturers Life Insurance Company grew its position in UnitedHealth Group by 60.4% in the first quarter. The Manufacturers Life Insurance Company now owns 5,009,284 shares of the healthcare conglomerate’s stock valued at $2,580,442,000 after purchasing an additional 1,886,128 shares in the last quarter. Capital Research Global Investors grew its position in UnitedHealth Group by 8.3% in the first quarter. Capital Research Global Investors now owns 19,273,691 shares of the healthcare conglomerate’s stock valued at $9,829,129,000 after purchasing an additional 1,482,338 shares in the last quarter. Finally, Invesco Ltd. grew its position in UnitedHealth Group by 28.3% in the first quarter. Invesco Ltd. now owns 6,018,008 shares of the healthcare conglomerate’s stock valued at $3,069,002,000 after purchasing an additional 1,328,237 shares in the last quarter. 87.25% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 1.1 %

UNH opened at $517.46 on Friday. UnitedHealth Group Incorporated has a fifty-two week low of $383.12 and a fifty-two week high of $553.29. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77. The firm has a market capitalization of $484.02 billion, a price-to-earnings ratio of 27.02, a PEG ratio of 1.61 and a beta of 0.76. The company’s 50 day moving average price is $530.11 and its two-hundred day moving average price is $512.45.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, topping analysts’ consensus estimates of $5.24 by $0.33. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The firm had revenue of $80.33 billion for the quarter, compared to analyst estimates of $79.68 billion. During the same period in the previous year, the firm posted $4.70 EPS. The company’s revenue for the quarter was up 12.6% compared to the same quarter last year. As a group, research analysts predict that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Monday, September 12th were paid a $1.65 dividend. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.28%. The ex-dividend date was Friday, September 9th. UnitedHealth Group’s dividend payout ratio is currently 34.46%.

Insider Activity

In other news, Director Stephen J. Hemsley sold 99,312 shares of the company’s stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $534.27, for a total value of $53,059,422.24. Following the sale, the director now directly owns 787,372 shares of the company’s stock, valued at approximately $420,669,238.44. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, CAO Thomas E. Roos sold 465 shares of the business’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $542.37, for a total transaction of $252,202.05. Following the transaction, the chief accounting officer now owns 34,786 shares in the company, valued at approximately $18,866,882.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Stephen J. Hemsley sold 99,312 shares of the business’s stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the transaction, the director now owns 787,372 shares in the company, valued at approximately $420,669,238.44. The disclosure for this sale can be found here. In the last three months, insiders have sold 139,051 shares of company stock valued at $74,450,958. 0.40% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on UNH. Morgan Stanley raised their target price on shares of UnitedHealth Group from $570.00 to $587.00 in a research report on Monday, July 18th. SVB Leerink raised their target price on shares of UnitedHealth Group from $600.00 to $625.00 and gave the stock an “outperform” rating in a research note on Monday, July 18th. Credit Suisse Group raised their target price on shares of UnitedHealth Group from $575.00 to $579.00 and gave the stock an “outperform” rating in a research note on Monday, July 18th. Mizuho raised their target price on shares of UnitedHealth Group from $550.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, August 10th. Finally, UBS Group lifted their price objective on shares of UnitedHealth Group from $545.00 to $570.00 and gave the stock a “neutral” rating in a research note on Thursday, July 21st. Three investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $586.40.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.